Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Z2RR
|
||||
| Former ID |
DNC014650
|
||||
| Drug Name |
2-Aminomethyl-pyrrolidine-3,4-diol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C5H12N2O2
|
||||
| Canonical SMILES |
C1C(C(C(N1)CN)O)O
|
||||
| InChI |
1S/C5H12N2O2/c6-1-3-5(9)4(8)2-7-3/h3-5,7-9H,1-2,6H2
|
||||
| InChIKey |
PTUICKYMXFZVGV-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Maltase-glucoamylase, intestinal | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Galactose metabolism | ||||
| Starch and sucrose metabolism | |||||
| Metabolic pathways | |||||
| Carbohydrate digestion and absorption | |||||
| PathWhiz Pathway | Starch and Sucrose Metabolism | ||||
| WikiPathways | Metabolism of carbohydrates | ||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2001 Sep 17;11(18):2489-93.Derivatives of (2R,3R,4S)-2-aminomethylpyrrolidine-3,4-diol are selective alpha-mannosidase inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.